Crossref
Inflammatory bowel diseases’s treatment in 2022
Hépato-Gastro & Oncologie Digestive · 2022
DOI: 10.1684/hpg.2017.2483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hépato-Gastro & Oncologie Digestive, 2022. Verfasst von Xavier Treton.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Treton, X. (2022). Inflammatory bowel diseases’s treatment in 2022. Hépato-Gastro & Oncologie Digestive. https://doi.org/10.1684/hpg.2017.2483
Vancouver
Treton X. Inflammatory bowel diseases’s treatment in 2022. Hépato-Gastro & Oncologie Digestive. 2022. doi:10.1684/hpg.2017.2483
BibTeX
@article{Treton2022,
author = {Treton, Xavier},
title = {Inflammatory bowel diseases’s treatment in 2022},
journal = {Hépato-Gastro & Oncologie Digestive},
year = {2022},
doi = {10.1684/hpg.2017.2483}
}
EUVIMED